A Phase I Trial of Lapatinib in Combination With Carboplatin in Patients With Platinum Sensitive Recurrent Epithelial Ovarian Cancer.
Phase of Trial: Phase I
Latest Information Update: 22 Dec 2009
At a glance
- Drugs Carboplatin; Lapatinib
- Indications Ovarian cancer
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 22 Dec 2009 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 22 Dec 2009 Planned end date (Apr 2007) added as reported by ClinicalTrials.gov.